Zusammenfassung
Die Entwicklung der hepatobiliären Chirurgie als eigenes Spezialgebiet reflektiert die zunehmende Weiterentwicklung in der operativen Therapie der Lebermalignome. Die Zunahme der Chirurgie der Lebertumoren beruht zum einen auf einem Anstieg der Inzidenz sowie einer verbesserten Diagnostik, zum anderen auf anhaltendem Enthusiasmus über den Erfolg chirurgischen Vorgehens als Teil multimodaler Therapie, um auch in scheinbar inkurablen Situationen eine Tumorreduktion zu erreichen. Des weiteren sind in den letzten 30 Jahren einige neue Tumorkategorien erkannt und neue ätiologische Faktoren für die Malignomentstehung identifiziert worden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adam R, Akpinar E, Johann M et al. (1997) Place of cryosurgery in the treatment of liver tumors. Ann Surg 225: 39
Armour FR, Babineau T, Bleday R, Seele G (1993) Laparoscopy/toracoscopy for staging: 1. Staging endoscopy in surgical oncology. Semin Surg Oncol 9: 51–55
Beasley RP, Hwang LY, Lin CC, Chein CS (1981) Hepatocellular carcinoma and hepatitis B virus: A prospective Study of 22707 men in Taiwan. Lancet II: 1129–1133
Bismuth H, Fecteau A (1998) Kombinationstherapie in der Onkologie - das hepatocelluläre Carcinom. Chirurg 69: 360365
Bismuth H, Houssin D, Castaing D (1982) Major and minor segmentectomies „Reglees“ in liver surgery. World J Surg 6: 10
Bismuth H, Chiche L, Adam R et al. (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218: 145–151
Bosch FX (1997) Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E (eds) Liver cancer. Churchill Livingstone, New York, pp 13–28
ne, New York Edinburgh London Madrid Melbourne Tokyo Bruix J (1997) Treatment of hepatocellular carcinoma. Hepato-logy 25: 259–262
Busuttil R, Farmer DG (1996) The surgical treatment of primary hepatobiliary malignancy. Liver Transplant Surg 2: 114130
Caine R, Yamanoi A, Oura S, Kawamura M (1993) Liver transplantation for hepatocellular carcinoma. Surg Today 23: 1–3
Carr BI, Selby R, Madariaga J et al. (1993) Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transpl Proc 25: 1128–1129
Carriaga MT, Henson DE (1994) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75: 171–190
Casavilla A, Marsh JW, Iwatsuki S et al. (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185: 429–436
Chang MH, Chen CJ, Lai MS et al. (1997) Universal hepatitis B vaccination in Taiwan and incidence of hepatocellular carcinoma in children. N Engl J Med 336: 1855–1859
Chau GY, Lui WY, Tsay SH et al. (1997) Prognostic significance of surgical margin in hepatocellular carcinoma resection: An analysis of 165 Childs’A patients. J Surg Oncol 66: 122
Chijiiwa K, Ichimiya H, Kuroki S et al. (1993) Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet 177: 279–282
Choi BI, Han JK, Song IS (1991) Intraoperative sonography of hepatocellular carcinoma: Detection of lesions and validity in surgical resection. Gastrointest Radiol 16: 329–333
Chou FF, Sheen-Chen SM, Chen YS et al. (1997) Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44: 760–765
Chu KM, Lai ECS, Al-Hadeedi S et al. (1997) Intrahepatic cholangiocarcinoma. World J Surg 21: 301–306
Clavien PA, Yadav S, Sindram D, Bentley RC (2000) Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232: 155–162
CLIP-Group (1998) Tamoxifen in treatment of hepatocellular carcinoma: A randomized controlled trial. Lancet 352: 1720
Colleoni M, Audisio RA, De Braud F et al. (1998) Practical considerations in the treatment of hepatocellular carcinoma. Drugs 55: 367–382
Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15: 225–236
Couinaud CJ (1957) Le fois. Etudes anatomiques et chirurgicales. Masson, Paris
Craig J, Peters R, Edmonson H, Omata M (1980) Fibrolamellar carcinoma of the liver. A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46: 372–379
DeBaere T, Roche A, Elias D et al. (1996) Preoperative portal vein embolisation for extension of hepatectomy indications. Hepatology 24: 1386–1391
DiBisceglie AM (1997) Hepatitis C and hepatocellular carcinoma. Hepatology 26: 34S - 38S
DiBisceglie AM, Carithers RL Gores GJ (1998) Hepatocellular carcinoma Hepatology 28: 1161–1165
Dusheiko GM, Hobbs KE, Dick R, Burroughs AK (1992) Treatment of small hepatocellular carcinomas. Lancet 340: 285288
Ebara M, Ohto M, Sugiura N et al. (1990) Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 5: 616–626
Elias D, Desruennes E, Lasser A (1991) Prolonged intermittent clamping of the portal triad during hepatectomy. Br J Surg 78: 42–44
Evans PM, Vogt DP, Mayes JT et al. (1998) Liver resection using total vascular exclusion. Surgery 124: 807–813
Ezaki T, Seo Y, Tomoda H et al. (1992) Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease. Br J Surg 79: 224–226
Farges O, Noun R, Sauvanet A et al. (1998) Routine use of total hepatic vascular exclusion in major hepatectomy is not necessary. Hepatogastroenterology 45: 370–375
Farhi DC, Shikes RH, Murari PJ, Silverberg SG (1983) Hepato- cellular carcinoma in young people. Cancer 52: 1516–1525
Farmer D, Rosove M, Shaked A, Busuttil R (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 219: 236–247
Fujiyama S, Morishita T, Hashiguchi O, Sato T (1988) Plasma abnormal prothrombin (des-gamma-prothrombin) as a marker of hepatocellular carcinoma. Cancer 61: 1621–1628
Grazi GL, Mazziotti A, Jovine E et al. (1997) Total vascular exclusion of the liver during hepatic surgery. Selective use, extensive use, or abuse? Arch Surg 132: 1104–1109
Groupe d’Etude et de Traitment du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332: 1256–1261
Hall A, Winter P, Wright R (1985) Mortality of hepatitis B posi- tive blood donors in England and Wales. Lancet I: 91–93
Hamamura K, Shiratori Y, Shiina S et al. (2000) Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy pro-thrombin and low serum alpha-fetoprotein. Cancer 88: 1557–1564
Hannoun L, Delriviere L, Gibbs P et al. (1996) Major extended hepatic resections in diseased livers using hypothermic protection. J Am Coll Surg 183: 597–605
Hardy J, Tancheroen S, Shulkes A (1995) Comparison of continuous versus intermittent ischemia-reperfusion during liver resection in an experimental model. Br J Surg 82: 833–836 Harrison LE, Fong Y, Klimstra DS et al. (1998) Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85: 1068–1070
Healey JE, Schroy PC (1953) Anatomy of the biliary ducts within the human liver. Analysis of the prevailing pattern of branchings and the major variations of the biliary ducts. Arch Surg 66: 599–616
Herfarth C, Heuschen UA, Lamade W et al. (1995) Rezidiv-Resektionen an der Leber bei primären and sekundären Lebermalignomen. Chirurg 66: 949–958
Hiatt JR, Gabbay J, Busuttil RW (1994) Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 220: 50
Hohenberger P (1996) Hemihepatektomie rechts von frontal–Alternative zum konventionellen Vorgehen. Chirurg 67: 944–948
Huang, Y, Wu JC, Chau GY et al. (1999) Supportive treatment, resection and transcatheter arterial chemoembolisation in resectable hepatocellular carcinoma: An analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 11: 315–321
Imai I, Kawata S, Tamura S et al. (1998) Relation of Interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Ann Intern Med 129: 94–99
Imamura H, Shimada R, Kubota M et al. (1999) Preoperative portal vein embolisation: An audit of 84 patients. Hepatology 29: 1099–1105
Inoue K, Makuuchi M, Takayama T et al. (2000) Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127: 498–505
Isozacki H, Okajima K, Kobayashi M (1995): Experimental study of liver injury after partial hepatectomy with intermittent or continuous hepatic vascular occlusion. Eur Surg Res 27: 313–322
Iwatsuki S, Starzl TE, Sheahan DG et al. (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214: 221–229
Jacobson LP, Zhang BC, Zhu YR et al. (1997) Oltipraz chemoprevention trial in Qidong, people’s republic of China: Study design and clinical outcomes. Cancer Epidemiol Biomarkers Prey 6: 257–265
Jones D, Koorey D (1987) Hepatic carcinoma. Screening studies and markers. Gastroenterol Clin North Am 16: 563–573
Kawarada Y, Mizumoto R (1990) Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 37: 176–181
Köckerling F, Schneider C, Scheuerlein H, Scheidbach H (1999) Intrahepatische Gefäßanatomie der Leber nach Regeneration. In: Köckerling F, Waclawiczek H (Hrsg) Leberchirurgie. Barth, Heidelberg Leipzig, S 67
Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: A population-based study. Scand J Gastroenterol 32: 1042–1045
Lai EC, Ng IO, You KT et al. (1991) Hepatectomy for large hepatocellular carcinoma: The optimal resection margin. World J Surg 15: 141–145
Lamadé W, Glombitza G, Fischer L et al. (2000) The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg 135: 1256–1261
Lasky T, Magder L (1997) Hepatocellular carcinoma p53 G-T transversions at codon 249: The fingerprint of aflatoxin exposure? Environ Health Perspect 105: 392–397
Lippert H (1999) Technik der Hemihepatektomie. In: Köckerling F, Waclawiczek HW (Hrsg) Leberchirurgie. Barth, Heidelberg Leipzig, S 146
Liu C, Fan ST, Lo CM et al. (2000 a) Anterior approch for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 232: 25–31
Liu C, Fan ST, Ng IO et al. ( 2000 b) Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study. Am J Gastroenterol 95: 218–222
Livraghi T, Giorgio A, Marin G et al. (1995) Hepatocellular carcinoma with cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 197: 101–108
LlovetJM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 30: 1434–1440
Maier KP (1998) Cirrhosis of the liver as a precancerous condition. Schweiz Rundsch Med Prax 87: 1462–1465
Majno PE, Adam R, Bismuth H et al. (1998) Influence of preoperative transarterial lipiodol chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226: 688
Matsumata T, Kanematsu K, Shirabe T et al. (1990) Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg 77: 677–680
Mayer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: Results in 207 Patients. Transplantation 69: 1633–1637
Mazziotti A, Cavallari A (1997) Techniques in liver surgery. Greenwich Medical Media, London
Mir-Nadjlessi SH, Farmer RG, Sivak MV (1987) Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis. Dig Dis Sci 32: 145–154
Molmenti EP, Marsh JW, Dvorchik I et al. (1999) Hepatobiliary malignancies. Primary hepatic malignant neoplasms. Surg Clin North Am 79: 43–57
Neuhaus P, Bechstein Wo, Lefebre B et al. (1989) Effect of aprotinin on intraoperative bleeding and fibirinolysis in liver transplantation. Lancet 8668: 924–925
Neuhaus P, Jonas S, Bechstein WO et al. (1999) Liver transplantation for hepatocellular carcinoma. Transplant Proc 31: 469–471
Niederau C, Fischer R, Purschel A et al. (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110: 1107–1119
Nonami T, Harada A, Kurokawa T et al. (1996) Advances in hepatic resektion and results for hepatocellular carcinoma. Sem Surg Oncol 12: 183–188
Novell R, Hilson A, Hobbs K (1991) Ablation of recurrent primary liver cancer using 131 I-lipiodol. Postgrad Med J 67: 393–395
Okuda K (1992) Hepatocellular carcinoma: Recent progress. Hepatology 15: 948–963
Otto G, Richter GM, Herfarth C (1997) Bedeutung bildgebender Verfahren für die chirurgische Indikationsstellung bei soliden Lebertumoren. Chirurg 68: 334–345
Otto G, Heuschen U, Hofmann Wet al. (1998) Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. Ann Surg 227: 424–432
Patel AH, Harnois DM, Klee GG et al. (2000) The utility of CA 19–9 in the diagnosis of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 95: 204–207
Peters M, Wellek S, Dienes HP et al. (1994) Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol 32: 146–151
Pichlmayr R, Lamesch P, Weimann A et al. (1995) Surgical treatment of cholangiocellular carcinoma. World J Surg 19: 8388
Pinna AD, Iwatsuki S, Lee RG et al. (1997) Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26: 877–883
Pitt HA, Dooley WC, Yeo CJ, Cameron JL (1995) Malignancies of the biliary tree. Curr Probl Surg 32: 1–90
Poon RT, Fan ST, Ng I, Wong J (2000) Significance of resection margin in hepatectomy for hepatocellular carcinoma. Ann Surg 231: 544–551
Propst A, Propst T, Waldenberger P et al. (1995) Das hepatozelluläre Karzinom. Schweiz Med Wochenschr 125: 2137–2142
Ranjan D, Johnston T (1998): Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 45: 1369–1374
Rau H, Meyer G, Jauch K et al. (1996) Leberresektion mit dem Wasserjet: Konventionell and laparoskopisch. Chirurg 67: 546–551
Ringe B, Pichlmayr R, Wittekind C, Tusch G (1991) Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 15: 270–285
Ruffin MT (1990) Fibrolamellar hepatoma. Am J Gastroenterol 85: 577–581
Schafer D, Sorrell M (1999) Hepatocellular carcinoma. Lancet 353: 1253–1257
Schmielau J, Klempnauer J, Schmiegel W (1997) Cholangio carzinome. Internist 38: 970–976
Soto JA, Barish MA, Yucel EK et al. (1996) Magnetic resonance cholangiography: Comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology 110: 589–597
Stone MJ, Klintmalm BG, Polter D et al. (1993) Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma. Gastroenterology 104: 196–202
Suehiro T, Matsumata T, Itasaka H et al. (1995) Des-gammacarboxy prothrombin and proliferative activity of hepatocellular carcinoma. Surgery 117: 682–691
Takada S, Koike K (1990) Transactivation funcion of a 3’truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissue. Proc Natl Acad Sci U S A 87: 5628–5632
Takata M, Yamanaka N, Tanaka T et al. (2000) What patients can survive disease free after complete resection for hepatocellular carcinoma? A multivariate analysis. Jpn J Clin Oncol 30: 75–81
Viebahn R, Lauchart W, Becker H (1989) Chirurgische Therapie der Leber-and Gallenwegstumoren. Ultraschall 10: 119–122
Vollmar B, Glasz J, Leiderer R et al. (1994) Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145: 1421–1431
Wang J, Zindy F, Chenivesse X et al. (1992) Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 7: 1653–1656
Weitz IC, Liebmann HA (1993) Des-gamma-carboxy (abnormal) prothrombin and HCC: A critical review. Hepatology 18: 990–997
Yamamoto Y, Ikai I, Kume M, Sakai Y (1999) New simple technique for hepatic parenchymal resection using CUSA and bipolar cautery equipped with a channel for water dripping. World J Surg 23: 1032–1037
Yamauchi M, Nakahara M, Maezawa Yet al. (1993) Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 88: 39–43
Yeh TS, Jan YY, Tseng JH et al. (2000) Malignant perihilar bilia- Zhou X, Zhou T, Yu Y, Ma A (1988) Clinical evaluation of cryory obstruction: Magnetic resonance cholangiopancreato- surgery in the treatment of primary liver cancer. Cancer 61:graphic findings. Am J Gastroenterol 95: 432–440 1889–1892
Zapletal C, Maksan SM, Weiss G et al. (1999) Ischemic preconditioning improves liver microcirculation after ischemia/reperfusion. Transplant Proc 31: 3260–3262
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Klar, E., Angelescu, M., Herfarth, C. (2001). Chirurgische Therapie primärer maligner Lebertumoren. In: Siewert, J.R., Harder, F., Rothmund, M. (eds) Praxis der Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09420-4_32
Download citation
DOI: https://doi.org/10.1007/978-3-662-09420-4_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-09421-1
Online ISBN: 978-3-662-09420-4
eBook Packages: Springer Book Archive